Selected article for: "negative conversion and nucleic acid negative conversion"
Author: Yueping Li; Zhiwei Xie; Weiyin Lin; Weiping Cai; Chunyan Wen; Yujuan Guan; Xiaoneng Mo; Jian Wang; Yaping Wang; Ping Peng; Xudan Chen; Wenxin Hong; Guangming Xiao; Jinxin Liu; Lieguang Zhang; Fengyu Hu; Feng Li; Feng Li; Fuchun Zhang; Xilong Deng; Linghua Li
Title: An exploratory randomized, controlled study on the efficacy and safety of lopinavir/ritonavir or arbidol treating adult patients hospitalized with mild/moderate COVID-19 (ELACOI)
  • Document date: 2020_3_23
    • ID: 9hknw4ws_22
    Snippet: The primary outcome was the time of positive-to-negative conversion of SARS-CoV-2 nucleic acid from the initiation of treatment to day 21, with the enrollment day as the first day of treatment. The secondary outcomes included All rights reserved. No reuse allowed without permission......
    Document: The primary outcome was the time of positive-to-negative conversion of SARS-CoV-2 nucleic acid from the initiation of treatment to day 21, with the enrollment day as the first day of treatment. The secondary outcomes included All rights reserved. No reuse allowed without permission.

    Search related documents:
    Co phrase search for related documents
    • enrollment day and treatment day: 1, 2, 3, 4, 5
    • enrollment day and treatment day enrollment day: 1
    • negative positive conversion and nucleic acid: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • negative positive conversion and primary outcome: 1, 2, 3, 4
    • negative positive conversion and SARS nucleic acid: 1, 2, 3, 4, 5, 6, 7
    • negative positive conversion and SARS nucleic acid negative positive conversion: 1, 2, 3, 4, 5, 6
    • negative positive conversion and secondary outcome: 1
    • negative positive conversion and treatment initiation: 1
    • nucleic acid and primary outcome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • nucleic acid and SARS nucleic acid: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • nucleic acid and SARS nucleic acid negative positive conversion: 1, 2, 3, 4, 5, 6, 7
    • nucleic acid and secondary outcome: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • nucleic acid and treatment day: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
    • nucleic acid and treatment initiation: 1, 2, 3, 4
    • primary outcome and SARS nucleic acid: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • primary outcome and SARS nucleic acid negative positive conversion: 1
    • primary outcome and secondary outcome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • primary outcome and treatment day: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • primary outcome and treatment initiation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19